Eisai Co (Germany) Today
| EII Stock | EUR 30.05 1.24 4.30% |
Performance0 of 100
| Odds Of DistressOver 64
|
Eisai Co is trading at 30.05 as of the 2nd of December 2024. This is a 4.30 percent increase since the beginning of the trading day. The stock's lowest day price was 29.07. Eisai Co has more than 64 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Eisai Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of May 2024 and ending today, the 2nd of December 2024. Click here to learn more.
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. Eisai Co., Ltd. was founded in 1941 and is headquartered in Tokyo, Japan. EISAI LTD operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. The company has 286.7 M outstanding shares. More on Eisai Co
Moving together with Eisai Stock
Moving against Eisai Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Eisai Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Eisai Co's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Eisai Co or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
Eisai Co (EII) is traded on Frankfurt Exchange in Germany and employs 11,322 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 14.48 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Eisai Co's market, we take the total number of its shares issued and multiply it by Eisai Co's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Eisai Co classifies itself under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 286.7 M outstanding shares.
Eisai Co has accumulated about 2.65 B in cash with 117.59 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.25.
Check Eisai Co Probability Of Bankruptcy
Ownership AllocationEisai Co holds a total of 286.7 Million outstanding shares. 30% of Eisai Co outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Eisai Ownership Details
Eisai Co Risk Profiles
Although Eisai Co's alpha and beta are two of the key measurements used to evaluate Eisai Co's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.55 | |||
| Standard Deviation | 2.58 | |||
| Variance | 6.66 | |||
| Risk Adjusted Performance | (0.08) |
Eisai Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Eisai Co without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Eisai Co Corporate Management
Elected by the shareholders, the Eisai Co's board of directors comprises two types of representatives: Eisai Co inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Eisai. The board's role is to monitor Eisai Co's management team and ensure that shareholders' interests are well served. Eisai Co's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Eisai Co's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yanhui Feng | VP | Profile | |
| Gary Hendler | VP Region | Profile | |
| Kenta Takahashi | Gen VP | Profile | |
| Haruo Naito | Representative CEO | Profile | |
| Tatsuyuki Yasuno | CFO VP | Profile | |
| Nadeem Sarwar | President | Profile | |
| Yosuke Akita | Chief VP | Profile |
Other Information on Investing in Eisai Stock
Eisai Co financial ratios help investors to determine whether Eisai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eisai with respect to the benefits of owning Eisai Co security.